These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 30104454)

  • 1. Efavirenz oral delivery via lipid nanocapsules: formulation, optimisation, and ex-vivo gut permeation study.
    Varshosaz J; Taymouri S; Jahanian-Najafabadi A; Alizadeh A
    IET Nanobiotechnol; 2018 Sep; 12(6):795-806. PubMed ID: 30104454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Organogel Nanoparticles as a New Way to Improve Oral Bioavailability of Poorly Soluble Compounds.
    Martin B; Garrait G; Beyssac E; Goudouneche D; Perez E; Franceschi S
    Pharm Res; 2020 May; 37(6):92. PubMed ID: 32394200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation and characterization of tetrandrine-phospholipid complex loaded lipid nanocapsules as potential oral carriers.
    Zhao YQ; Wang LP; Ma C; Zhao K; Liu Y; Feng NP
    Int J Nanomedicine; 2013; 8():4169-81. PubMed ID: 24204145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and optimization of sulforaphane-loaded nanostructured lipid carriers by the Box-Behnken design for improved oral efficacy against cancer: in vitro, ex vivo and in vivo assessments.
    Soni K; Rizwanullah M; Kohli K
    Artif Cells Nanomed Biotechnol; 2018; 46(sup1):15-31. PubMed ID: 29183147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanosuspension of efavirenz for improved oral bioavailability: formulation optimization, in vitro, in situ and in vivo evaluation.
    Patel GV; Patel VB; Pathak A; Rajput SJ
    Drug Dev Ind Pharm; 2014 Jan; 40(1):80-91. PubMed ID: 23323843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymeric versus lipid nanocapsules for miconazole nitrate enhanced topical delivery:
    Abdel-Rashid RS; Helal DA; Alaa-Eldin AA; Abdel-Monem R
    Drug Deliv; 2022 Dec; 29(1):294-304. PubMed ID: 35037528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nose to brain delivery of mirtazapine via lipid nanocapsules: Preparation, statistical optimization, radiolabeling, in vivo biodistribution and pharmacokinetic study.
    Ibrahim MM; Basalious EB; El-Nabarawi MA; Makhlouf AI; Sayyed ME; Ibrahim IT
    Drug Deliv Transl Res; 2024 Sep; 14(9):2539-2557. PubMed ID: 38376620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipid nanocarriers improve paclitaxel transport throughout human intestinal epithelial cells by using vesicle-mediated transcytosis.
    Roger E; Lagarce F; Garcion E; Benoit JP
    J Control Release; 2009 Dec; 140(2):174-81. PubMed ID: 19699246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous delivery of furosemide using lipid-based versus polymer-based nanocapsules:
    Kamel YN; El-Marakby EM; Gad HA
    Pharm Dev Technol; 2024 Sep; 29(7):738-750. PubMed ID: 39105766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Solid lipid nanoparticles (SLN) of Efavirenz as lymph targeting drug delivery system: Elucidation of mechanism of uptake using chylomicron flow blocking approach.
    Makwana V; Jain R; Patel K; Nivsarkar M; Joshi A
    Int J Pharm; 2015 Nov; 495(1):439-446. PubMed ID: 26367780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and in vitro evaluations of new decitabine nanocarriers for the treatment of acute myeloid leukemia.
    Briot T; Roger E; Lautram N; Verger A; Clavreul A; Lagarce F
    Int J Nanomedicine; 2017; 12():8427-8442. PubMed ID: 29200853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced oral bioavailability of Tanshinone IIA using lipid nanocapsules: Formulation, in-vitro appraisal and pharmacokinetics.
    Ashour AA; Ramadan AA; Abdelmonsif DA; El-Kamel AH
    Int J Pharm; 2020 Aug; 586():119598. PubMed ID: 32629068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design and Optimization of Cationic Nanocapsules for Topical Delivery of Tretinoin: Application of the Box-Behnken Design,
    Ebrahimi S; Mahjub R; Haddadi R; Vafaei SY
    Biomed Res Int; 2021; 2021():4603545. PubMed ID: 34934769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and characterization of a novel lipid nanocapsule formulation of Sn38 for oral administration.
    Roger E; Lagarce F; Benoit JP
    Eur J Pharm Biopharm; 2011 Sep; 79(1):181-8. PubMed ID: 21303693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of Oral Lipid Based Nano-formulation of Dapagliflozin: Optimization, in vitro Characterization and ex vivo Intestinal Permeation Study.
    Zafar A
    J Oleo Sci; 2020; 69(11):1389-1401. PubMed ID: 33132278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fabrication of solid lipid nanoparticles of lurasidone HCl for oral delivery: optimization,
    Patel MH; Mundada VP; Sawant KK
    Drug Dev Ind Pharm; 2019 Aug; 45(8):1242-1257. PubMed ID: 30880488
    [No Abstract]   [Full Text] [Related]  

  • 17. Fabrication of lipidic nanocarriers of loratadine for facilitated intestinal permeation using multivariate design approach.
    Verma S; Singh SK; Verma PR
    Drug Dev Ind Pharm; 2016; 42(2):288-306. PubMed ID: 26087658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formulation development and upscaling of lipid nanocapsules as a drug delivery system for a novel cyclic GMP analogue intended for retinal drug delivery.
    Urimi D; Widenbring R; Pérez García RO; Gedda L; Edwards K; Loftsson T; Schipper N
    Int J Pharm; 2021 Jun; 602():120640. PubMed ID: 33901599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repaglinide-loaded nanostructured lipid carriers with different particle sizes for improving oral absorption: preparation, characterization, pharmacokinetics, and
    Wu L; Zhao L; Su X; Zhang P; Ling G
    Drug Deliv; 2020 Dec; 27(1):400-409. PubMed ID: 31729898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation and Characterization of Puerarin-Loaded Lipid Nanocapsules.
    Zhai Y; Liu M; Wan M; Li Y; Zhang M; Zhai G
    J Nanosci Nanotechnol; 2015 Apr; 15(4):2643-9. PubMed ID: 26353476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.